Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Clinical trial NCT03754790 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03754790
- Sponsor
- Genzyme, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-09
- Primary completion
- 2026-11-05
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.